Latest news
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - BitgetBitget · Fri, 07 Aug 2026 20:41:25 GMTFidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock TitanStock Titan · Fri, 07 Aug 2026 20:28:58 GMTCHOP, Penn-founded lab win federal millions for rare disease gene therapy - Northeast TimesNortheast Times · Thu, 06 Aug 2026 03:00:00 GMTBioNexus Gene Lab (BGLC) CEO files Form 3 showing 0.0000 shares - Stock TitanStock Titan · Fri, 31 Jul 2026 21:52:39 GMTBioNexus Gene Lab Corp (BGLC) director reports holding 0 common shares - Stock TitanStock Titan · Fri, 31 Jul 2026 21:51:16 GMTBioNexus Gene Lab (BGLC) director files Form 3 with zero shares - Stock TitanStock Titan · Fri, 31 Jul 2026 21:04:06 GMTBioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock TitanStock Titan · Fri, 31 Jul 2026 21:02:44 GMTBioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingViewTradingView · Mon, 27 Jul 2026 13:56:17 GMT